By 2031, the women’s health diagnostics market will exceed $4.66 billion from $2.29 billion in 2021, with a CAGR of 7.3% in the next few years (ie, 2021-2031). . product description
NEW YORK, June 27, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Women’s Health Diagnostics Market: Segmentation: By Type, End User and Region – Global Analysis of Market Size, Share and Trends 2019 – 2021 year and projections to 2031”- https://www.reportlinker.com/p06288826/?utm_source=GNW
Women’s health is the field of medicine devoted to the treatment and diagnosis of diseases and ailments that affect women’s health. Some women-related diseases, such as breast cancer, cervical cancer, ovarian cancer, menopause, and pregnancy, are diagnosed and monitored using women’s health diagnostic methods, including screening, testing, and surveillance. For the diagnosis of women’s health-related disorders, a variety of tests are available. Medical diagnostic equipment, such as biopsy equipment, imaging and monitoring systems, mammography systems, and other equipment, help identify cancer, clear obstructions, and capture images of internal organs for disease screening and diagnosis.
The women’s health diagnostics market is expected to grow at a CAGR of 7.3% by 2031.
The key drivers driving the growth of the women’s health diagnostics market include increasing global geriatric female population, increasing frequency of chronic and lifestyle disorders, and increasing demand for point-of-care diagnostic tests. Furthermore, government initiatives to increase women’s health awareness across the globe are driving the growth of the women’s health diagnostics market. The increased use of imaging techniques in diagnosis is due to the increase in new applications of imaging techniques.
Global Women’s Health Diagnostics Market: Segmentation
Diagnostic testing segment is expected to lead at the highest CAGR during 2021-31
On the basis of Type, the Women’s Health Diagnostics Market is segmented into Accessories & Consumables, Diagnostic Tests, and Diagnostic Devices. The diagnostic testing category has contributed the most to the market over the past few years. The women’s health diagnostic tests market is driven by increasing prevalence of various health-related diseases such as cancer and infertility among women, rising awareness of women’s health-related tests, high demand for point-of-care diagnostics testing, and the development of many diagnostic and imaging centers.
The hospital and clinic segment is expected to grow significantly during 2021-31
The global women’s health diagnostics market is segmented on the basis of end-users into hospitals and clinics, diagnostic and imaging centers, home care, and others. In previous years, the hospital and clinic category contributed the most to the market. Growth in the incidence of breast and ovarian cancer has led to a substantial increase in hospitalizations.
Demand for improved technology surges, cases of heart-related disease among women rise
The market is growing owing to the demand for improved technology and the increasing availability of diagnostic centers. The growth of the women’s health diagnostics market is driven by increasing prevalence of various health-related disorders such as infertility and breast cancer among women, high demand for point-of-care diagnostic tests, and rising awareness about women’s health . testing, and the development of numerous diagnostic and imaging centers. Furthermore, increasing healthcare spending, increasing awareness of malignancies, and availability of newer and more robust diagnostic techniques are expected to boost market growth in the near future.
Rising demand for testing kits due to rising cases is driving market growth
The increase in sales of home test kits is due to an increase in the number of instances, which is likely to drive the market’s revenue growth over the forecast period. The market is expected to grow owing to increasing implementation of point-of-care diagnostic tests and increasing number of diagnostic and imaging devices available globally.
High costs associated with women’s health diagnoses
High-cost imaging technology and scarcity of qualified personnel stifle market expansion. Furthermore, high prices of diagnostic tests, devices, and procedures, and insufficient reimbursement for diagnostic tests are expected to restrain the market growth.
Global Women’s Health Diagnostics Market: Key Players
Siemens Healthcare Pte Ltd
Company Profile, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Developments, Regional Presence, SWOT Analysis
F. Hoffmann-La Roche Ltd.
Koninklijke Philips NV
becton, dickinson & co.
other famous players
Global Women’s Health Diagnostics Market: Regions
The global women’s health diagnostics market is segmented into five major regions based on regional analysis: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The largest market share is in North America. Rising incidence of cancer among women, increasing focus of women’s health diagnostic device manufacturers to expand their presence in the region, and growing demand for fertility test monitors are factors contributing to the size of this segment. Furthermore, the growing popularity of POC diagnosis and PST procedures is expected to support the growth of the region during the forecast period.
Impact of COVID-19 on Women’s Health Diagnostics Market
To control and reduce the spread of the coronavirus (COVID-19), more countries around the world have closed borders and restricted travel since the beginning of 2020, resulting in hampered international trade and transportation. Due to uncertainties in the global economy and capital markets, the supply chain of women’s health diagnosis has been disrupted, and short-term demand has declined relatively.
The global women’s health diagnostics market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, YoY Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, YoY Growth, CAGR – Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, YoY Growth, CAGR – UK, France, Germany, Italy, Spain and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, YoY Growth, CAGR – India, China, Japan and Rest of Asia Pacific
Middle East & Africa Market Size, Share, Trends, Opportunities, YoY Growth, CAGR – Rest of Middle East & Africa
The Global Women’s Health Diagnostics Market report also includes the following analysis:
Women’s Health Diagnostics Market Segmentation:
Accessories and Consumables
By end user
Hospitals and Clinics
Diagnostic and Imaging Center
Women’s Health Diagnostics Market Dynamics
Women’s Health Diagnostics Market Size
Competition and participating companies
market value chain
Market Drivers and Restraints
Women’s Health Diagnostics Market Report Scope and Segmentation
report property details
Market size to be worth $22.9 billion in 2021
2031 revenue forecast of $46.6 billion
7.3% CAGR from 2021 to 2031
Estimated base year 2020
Quantity Unit Revenue and CAGR from 2021 to 2031
Report Scope Revenue forecasts, company rankings, competitive landscape, growth factors and trends
Segmentation covers types, end users and regions
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa (MEA)
Major companies introduced Siemens Healthcare Private Limited, Hologic, Inc., GE Healthcare, F. Hoffmann-La Roche Ltd., bioMérieux SA, Koninklijke Philips NV, Abbott and BD.
Read the full report: https://www.reportlinker.com/p06288826/?utm_source=GNW
about report linker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you can get all the market research you need right away in one place.
CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001